Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2026-02-12 @ 3:11 AM
Study NCT ID:
NCT01870505
Status:
COMPLETED
Last Update Posted:
2024-12-09
First Post:
2013-06-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-28
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-03
First Submit QC Date:
None
Study First Post Date:
2013-06-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-02-27
Results First Submit QC Date:
None
Results First Post Date:
2024-12-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-25
Last Update Post Date:
2024-12-09
Last Update Post Date Type:
ACTUAL